| 0.37 -0.02 (-5.13%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.51 | 1-year : | 0.57 |
| Resists | First : | 0.44 | Second : | 0.49 |
| Pivot price | 0.4  |
|||
| Supports | First : | 0.36 | Second : | 0.29 |
| MAs | MA(5) : | 0.38 |
MA(20) : | 0.4 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -1.1  |
Signal : | -1.5 |
| %K %D | K(14,3) : | 13.8 |
D(3) : | 15.6 |
| RSI | RSI(14): 3.7 |
|||
| 52-week | High : | 50 | Low : | 0.36 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ BIOT ] has closed above bottom band by 2.8%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 0.41 - 0.41 | 0.41 - 0.41 |
| Low: | 0.36 - 0.36 | 0.36 - 0.36 |
| Close: | 0.37 - 0.37 | 0.37 - 0.37 |
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.
Tue, 08 Sep 2026
Instinct Bio (BIOT) says Jakarta clinic build is progressing - Stock Titan
Fri, 04 Sep 2026
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives - The Manila Times
Fri, 04 Sep 2026
A planned Jakarta clinic has preliminary membership prices up to $3,000 a month. - Stock Titan
Wed, 29 Jul 2026
Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOT - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 29 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 12.1 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 213 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -0.01 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -37 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|